Børge G. Nordestgaard

University of Copenhagen — Denmark

Medicine · Health Sciences

191h-index166.4kcitations1.8kworks21.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(446), Diabetes, Cardiovascular Risks, and Lipoproteins(333), Genetic Associations and Epidemiology(189), Cancer, Lipids, and Metabolism(177), Chronic Obstructive Pulmonary Disease (COPD) Research(119)

Publications1.7k total

Feasibility of remnant cholesterol as a therapeutic target for atherosclerotic cardio-vascular disease.
PubMed·2026
Cardiovascular risk among giant cell arteritis patients
European Journal of Preventive Cardiology·2026
VLDL cholesterol and ASCVD risk: A population-based study
Journal of clinical lipidology·2026Open Access
C-reactive protein and prospective cardiometabolic risk: observational and Mendelian randomization study of ischemic stroke and all-cause death
Cardiovascular Diabetology·2025Open Access
Remnant cholesterol and particle number of VLDL subfractions in coronary artery disease: Pros and cons
Atherosclerosis·2025· 1 citedOpen Access
Elevated apoB due to high remnant cholesterol confers high risk of ASCVD without prompting sufficient lipid-lowering therapy: a guideline-based limitation and an unmet medical need
European Journal of Preventive Cardiology·2025
JCL roundtable: European perspective on comprehensive lipid management and cardiovascular health
Journal of clinical lipidology·2025
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk
New England Journal of Medicine·2025· 16 cited
Association of endogenous oxidants and antioxidants with risk of atherosclerotic cardiovascular disease
European Journal of Preventive Cardiology·2025
Focused update 2025 delle linee guida ESC/EAS 2019 per il trattamento delle dislipidemie
Giornale italiano di cardiologia·2025Open Access
High-sensitivity C-reactive protein - a biomarker in stroke subtypes
Neurological Research·2025Open Access
Metabolic dysfunction-associated steatotic liver disease, cardiometabolic risk factors, and cardiovascular disease
Atherosclerosis·2025· 1 citedOpen Access
Cardioprotective glucose-lowering drugs, statins, and risk of first-time atherosclerotic cardiovascular disease in Denmark: a nationwide cohort study
The Lancet Regional Health - Europe·2025· 1 citedOpen Access
Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk
European Heart Journal·2025· 2 citedOpen Access
Cholesterol‐lowering drug targets reduce risk of dementia: Mendelian randomization and meta‐analyses of 1 million individuals
Alzheimer s & Dementia·2025· 1 citedOpen Access
Sex differences in COPD in relation to smoking exposure: A population-based cohort study
Epidemiology·2025
Alpha-1 antitrypsin deficiency and risk of sleep apnea: A nationwide cohort study
Sleep Science·2025Open Access
Late Breaking Abstract - Alpha-1 antitrypsin deficiency associated with increased risk of venous thromboembolism: a nationwide cohort study in Denmark
Epidemiology·2025
Development of Clinical COPD from Pre-COPD
2025
Plasma levels of lipoprotein(a) in persons with HIV compared to the general population
AIDS·2025
page 1 of 84Next →

Frequent Co-authors

Anne Tybjærg‐Hansen(19), Henry N. Ginsberg(15), Kausik K. Ray(13), Alberico L. Catapano(13), Gerald F. Watts(12), Jan Borén(11), M. John Chapman(11), Robert A. Hegele(10), Marja‐Riitta Taskinen(10), Olov Wiklund(10), Erik S.G. Stroes(10), Éric Bruckert(9), Frederick J. Raal(9), L. Masana(9), Olivier Descamps(8), Stig E. Bojesen(8), Raúl D. Santos(8), Paul M. Ridker(7), Wolfgang Köenig(7), Petri T. Kovanen(7)